# A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion

> **NCT03197194** · PHASE3 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 70 (actual)

## Conditions studied

- Central Retinal Artery Occlusion

## Interventions

- **DRUG:** Alteplase
- **DRUG:** acetylsalicylic acid
- **DRUG:** Placebo Oral Tablet
- **DRUG:** placebo IV

## Key facts

- **NCT ID:** NCT03197194
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-08
- **Primary completion:** 2024-01-16
- **Final completion:** 2024-01-16
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03197194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03197194, "A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03197194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*